Test Bank for Ruppel’s Manual of Pulmonary Function Testing
12th Edition, By Mottram
Chapter 1 - 13 Updated
,Chapter 1: Indications for Pulmonary Function Testing Test Bank
MULTIPLE CHOICE
1. Who first popularized spirometry for the evaluation of pulmonary function?
a. August and Marie Krogh
b. Alvan Barach
c. John Severinghaus
d. John Hutchinson
ANS: D
Hutchinson popularized the concept of using VC to assess lung function, and the names he
gave to several other lung compartments are still used today.
DIF: 1 REF: p. 2 OBJ: None MSC: NBRC: None
2. Which of the following are indications for performing spirometry?
1. Assess the risk of lung resection.
2. Determine the response to bronchodilator therapy.
3. Assess the severity of restrictive lung disease.
4. Quantify the extent of COPD.
a. 1 and 4
b. 2 and 3
c. 1 , 2, and 4
d. 2 , 3, and 4
ANS: C
Spirometry cannot assess severity of restriction; for that you need to measure lung volumes (
see Box 1-2, Chapter 1).
DIF: 1 REF: p. 7 OBJ: EL-2 MSC: NBRC: None
3. The main indication for the measurement of lung volumes is to do which of the following?
a. Diagnose or assess the severity of restriction.
b. Evaluate the severity of pulmonary hypertension.
c. Determine the level of cardiopulmonary fitness.
d. Assess the risk of abdominal surgical procedures.
ANS: A
The most common reason for measuring lung volumes is to identify restrictive lung
disease. DIF: 1 REF: p. 35 OBJ: EL-2 MSC: NBRC: None
4. DLCO measurements may be indicated to evaluate pulmonary involvement in which of
the following systemic diseases?
, a. Asthma
b. Sarcoidosis
c. Exertional hypoxemia
d. Guillain-Barré syndrome
ANS: B
Sarcoidosis is the only systemic disease listed that affects gas exchange.
DIF: 1 REF: p. 9 | p. 19 | p. 21 | p. 35 OBJ: EL-2 MSC: NBRC: None
5. Blood gas analysis is used with patients with COPD to do which of the
following?
a. Monitor airway responsiveness.
b. Determine level of cardiopulmonary fitness.
c. Detect pulmonary hypertension.
d. Assess need for supplementary O2.
ANS: D
Blood gas analysis is most commonly used to determine the need for supplemental oxygen
and to manage patients who require ventilatory support.
DIF: 2 REF: p. 15 OBJ: EL-1
MSC: NBRC: CPFT 2A-2
6. Which of the following cause emphysema?
1. 1- Antitrypsin deficiency
2. Exposure to environmental pollutants
3. Radiation therapy
4. Cigarette smoking
a. 1 and 2
b. 3 and 4
c. 1 , 2, and 4
d. 2 , 3, and 4
ANS: C
Emphysema is caused primarily by cigarette smoking. Some emphysema is caused by the
absence of a protective enzyme. Chronic exposure to environmental pollutants can also
contribute to the development of emphysema.
DIF: 1 REF: p. 11 OBJ: EL-3 | AL-2 MSC: NBRC: None
7. An adult patient complains of chest tightness and cough whenever he jogs in cold
weather. These symptoms are consistent with which of the following?
a. Cystic fibrosis
b. Asthma
c. Pulmonary hypertension
d. Idiopathic pulmonary fibrosis
|
, ANS: sB
Agents sor sevents sthat scause san sasthmatic sepisode sare scalled striggers s(see sBox s1-7,
sChapter s1). sAntigens ssuch sas sanimal sdander, spollens, sand sdusts sare sthe smost scommon
striggers. sOther scommon striggers sinclude sexposure sto sair spollutants sand sexercise sin
scold sor sdry sair.
DIF: 2 REF: p. s16 OBJ: EL-3 MSC: sNBRC: sNone
8. Which sof sthe sfollowing sstatements sconcerning stumors sin sthe supper sairway sis strue?
a. There smay sbe svariable sor sfixed sobstruction.
b. Fixed sobstruction swill sbe spresent.
c. Variable sobstruction swill sbe spresent.
d. Small sairway sobstruction swill sresult.
ANS: sA
Tumors sinvolving sthe supper sairway smay scause svariable sor sfixed sobstruction.
DIF: 2 REF: p. s19 OBJ: EL-2
sMSC: sNBRC: sCPFT s3C-3
9. Sarcoidosis sis sa ssystemic sdisorder sthat susually scauses swhich sof sthe sfollowing?
a. A srestrictive sventilatory sdefect
b. An sobstructive sventilatory sdefect
c. Hyperreactive sairways
d. Primary spulmonary shypertension
ANS: sA
Restriction sis soften sassociated swith sthe sfollowing: sinterstitial slung sdiseases, sincluding
sidiopathic sfibrosis, spneumoconioses, sand ssarcoidosis.
DIF: 1 REF: p. s19 s| sp. s21 OBJ: EL-3 MSC: sNBRC: sNone
10. For swhich sof sthe sfollowing sconditions smight spulmonary sfunction stesting sbe
scontraindicated?
a. Vocal scord sdysfunction
b. Untreated spneumothorax
c. Congestive sheart sfailure s(CHF)
d. Bronchiolitis sobliterans
ANS: sB
Pulmonary sfunction stests sare susually scontraindicated sin sthe spresence sof spneumothorax.
sHowever, sundiagnosed spneumothorax smay spresent sa srisk sif spulmonary sfunction sstudies
sare sperformed.
DIF: 1 REF: p. s23 OBJ: EL-4
sMSC: sNBRC: sCPFT s2B-6
d.
11. Which sof sthe sfollowing scorrectly sdescribe(s) sappropriate sphysical smeasurements
|
12th Edition, By Mottram
Chapter 1 - 13 Updated
,Chapter 1: Indications for Pulmonary Function Testing Test Bank
MULTIPLE CHOICE
1. Who first popularized spirometry for the evaluation of pulmonary function?
a. August and Marie Krogh
b. Alvan Barach
c. John Severinghaus
d. John Hutchinson
ANS: D
Hutchinson popularized the concept of using VC to assess lung function, and the names he
gave to several other lung compartments are still used today.
DIF: 1 REF: p. 2 OBJ: None MSC: NBRC: None
2. Which of the following are indications for performing spirometry?
1. Assess the risk of lung resection.
2. Determine the response to bronchodilator therapy.
3. Assess the severity of restrictive lung disease.
4. Quantify the extent of COPD.
a. 1 and 4
b. 2 and 3
c. 1 , 2, and 4
d. 2 , 3, and 4
ANS: C
Spirometry cannot assess severity of restriction; for that you need to measure lung volumes (
see Box 1-2, Chapter 1).
DIF: 1 REF: p. 7 OBJ: EL-2 MSC: NBRC: None
3. The main indication for the measurement of lung volumes is to do which of the following?
a. Diagnose or assess the severity of restriction.
b. Evaluate the severity of pulmonary hypertension.
c. Determine the level of cardiopulmonary fitness.
d. Assess the risk of abdominal surgical procedures.
ANS: A
The most common reason for measuring lung volumes is to identify restrictive lung
disease. DIF: 1 REF: p. 35 OBJ: EL-2 MSC: NBRC: None
4. DLCO measurements may be indicated to evaluate pulmonary involvement in which of
the following systemic diseases?
, a. Asthma
b. Sarcoidosis
c. Exertional hypoxemia
d. Guillain-Barré syndrome
ANS: B
Sarcoidosis is the only systemic disease listed that affects gas exchange.
DIF: 1 REF: p. 9 | p. 19 | p. 21 | p. 35 OBJ: EL-2 MSC: NBRC: None
5. Blood gas analysis is used with patients with COPD to do which of the
following?
a. Monitor airway responsiveness.
b. Determine level of cardiopulmonary fitness.
c. Detect pulmonary hypertension.
d. Assess need for supplementary O2.
ANS: D
Blood gas analysis is most commonly used to determine the need for supplemental oxygen
and to manage patients who require ventilatory support.
DIF: 2 REF: p. 15 OBJ: EL-1
MSC: NBRC: CPFT 2A-2
6. Which of the following cause emphysema?
1. 1- Antitrypsin deficiency
2. Exposure to environmental pollutants
3. Radiation therapy
4. Cigarette smoking
a. 1 and 2
b. 3 and 4
c. 1 , 2, and 4
d. 2 , 3, and 4
ANS: C
Emphysema is caused primarily by cigarette smoking. Some emphysema is caused by the
absence of a protective enzyme. Chronic exposure to environmental pollutants can also
contribute to the development of emphysema.
DIF: 1 REF: p. 11 OBJ: EL-3 | AL-2 MSC: NBRC: None
7. An adult patient complains of chest tightness and cough whenever he jogs in cold
weather. These symptoms are consistent with which of the following?
a. Cystic fibrosis
b. Asthma
c. Pulmonary hypertension
d. Idiopathic pulmonary fibrosis
|
, ANS: sB
Agents sor sevents sthat scause san sasthmatic sepisode sare scalled striggers s(see sBox s1-7,
sChapter s1). sAntigens ssuch sas sanimal sdander, spollens, sand sdusts sare sthe smost scommon
striggers. sOther scommon striggers sinclude sexposure sto sair spollutants sand sexercise sin
scold sor sdry sair.
DIF: 2 REF: p. s16 OBJ: EL-3 MSC: sNBRC: sNone
8. Which sof sthe sfollowing sstatements sconcerning stumors sin sthe supper sairway sis strue?
a. There smay sbe svariable sor sfixed sobstruction.
b. Fixed sobstruction swill sbe spresent.
c. Variable sobstruction swill sbe spresent.
d. Small sairway sobstruction swill sresult.
ANS: sA
Tumors sinvolving sthe supper sairway smay scause svariable sor sfixed sobstruction.
DIF: 2 REF: p. s19 OBJ: EL-2
sMSC: sNBRC: sCPFT s3C-3
9. Sarcoidosis sis sa ssystemic sdisorder sthat susually scauses swhich sof sthe sfollowing?
a. A srestrictive sventilatory sdefect
b. An sobstructive sventilatory sdefect
c. Hyperreactive sairways
d. Primary spulmonary shypertension
ANS: sA
Restriction sis soften sassociated swith sthe sfollowing: sinterstitial slung sdiseases, sincluding
sidiopathic sfibrosis, spneumoconioses, sand ssarcoidosis.
DIF: 1 REF: p. s19 s| sp. s21 OBJ: EL-3 MSC: sNBRC: sNone
10. For swhich sof sthe sfollowing sconditions smight spulmonary sfunction stesting sbe
scontraindicated?
a. Vocal scord sdysfunction
b. Untreated spneumothorax
c. Congestive sheart sfailure s(CHF)
d. Bronchiolitis sobliterans
ANS: sB
Pulmonary sfunction stests sare susually scontraindicated sin sthe spresence sof spneumothorax.
sHowever, sundiagnosed spneumothorax smay spresent sa srisk sif spulmonary sfunction sstudies
sare sperformed.
DIF: 1 REF: p. s23 OBJ: EL-4
sMSC: sNBRC: sCPFT s2B-6
d.
11. Which sof sthe sfollowing scorrectly sdescribe(s) sappropriate sphysical smeasurements
|
